BERGISCH GLADBACH, Germany, June 10 /CNW/ - Miltenyi Biotec has acquired
Medic Tools AG from Zug, Switzerland. With this acquisition, Miltenyi Biotec
strengthens the portfolio in the area of sample preparation. "The innovative
and high-quality devices and techniques fit perfectly into the product range
of instruments, reagents, and services offered by Miltenyi Biotec", Miltenyi
Biotec CEO Dr. Boris Stoffel and Franz G. Bucher, Vice President and CEO of
Medic Tools AG, stated in a conjoint announcement.
As a first result of the previous cooperation, the gentleMACS(TM)
Dissociator was introduced into the market several months ago. The instrument
facilitates the generation of single-cell suspensions from tissues and thus,
helps generate the ideal starting material for the separation and isolation of
specific cell types using MACS(R) Technology. This procedure to separate cells
magnetically was developed by Miltenyi Biotec and is a research laboratory
The additional expertise of Medic Tools enables Miltenyi Biotec to
further engage in development projects in the area of sample preparation. "We
offer our biomedical research customers a complete solution", adds Dr.
Stoffel, "from sample preparation to cell separation, cell analysis,
cytological and molecular analysis."
The involved parties agreed that financial details of the transaction
should not be disclosed.
About Miltenyi Biotec
The company is one of the largest and most successful biotechnology
companies in Germany. More than 1,100 employees develop, produce and sell
products for biomedical research and clinical applications. The renowned MACS
Technology for magnetic separation of cells has become a standard technology
in research laboratories worldwide.
For further information:
For further information: Prof. Dr. Uwe Heinlein, Corporate
Communications, Miltenyi Biotec GmbH, Friedrich-Ebert-Str. 68, 51429 Bergisch
Gladbach, Germany, Phone +49-2204-8306-6590, E-mail firstname.lastname@example.org,